scRNA-seq analysis has identified distinct microglial subpopulations with unique glucose metabolism signatures, including a subset characterized by elevated GLUT1 expression, enhanced glycolysis, and reduced OXPHOS, which became more prevalent as AD pathology progressed [127]. This evidence concerns the gene SLC2A1 and Alzheimer disease.